Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	317.72	-441.36	105.66
Graham Fair Price	50.56	54.51	36.20
PEG	-87.65	0.08	-0.65
Price/Book	-0.17	1.51	1.51
Price/Cash Flow	131.98	18.60	-8.02
Prices/Earnings	-55.54	10.97	24.68
Price/Sales	-15.37	10.53	12.45
Price/FCF	131.98	18.60	-8.02
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-54.70	0.45	1.00
Operating Margin	114.53	0.37	0.17
ROA	118.54	< 0.005	< 0.005
ROE	0.02	0.03	124.55
ROIC	< 0.005	< 0.005	110.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.39	0.08	416.11
Dividends QOQ	< 0.005	0.02	223.09
EBIT QOQ	-0.34	1.53	357.49
EPS QOQ	-0.38	1.37	259.85
FCF QOQ	-7.59	1.43	-81.15
Revenue QOQ	-0.03	0.18	482.49
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-2128.98	-100.00
Days Sales Outstanding (DSO)	599.24	516.88	-13.74
Inventory Turnover	0.00	-0.04	-100.00
Debt/Capitalization	0.74	0.80	7.99
Quick Ratio	0.74	0.34	-54.03
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	61.67	61.96	0.47
Cash	50.67	57.41	13.30
Capex	-0.58	-0.51	11.89
Free Cash Flow	-11.63	5.03	-56.76
Revenue	7.49	8.88	18.52
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.41	1.40	241.13
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	62.60	-299.15	377.88
Naive Interpretation	Member

06 - Financial Health · Weak

Rating